申请人:Immunogen Inc.
公开号:US05585499A1
公开(公告)日:1996-12-17
Novel cytotoxic agents comprising a cell binding agent chemically linked to one or more analogue or derivative of CC-1065 are described. The therapeutic use of the cytotoxic agents is also described. These cytotoxic agents have therapeutic use because they deliver the cytotoxic drugs to a specific cell population in a targeted fashion.
本发明涉及一种包括细胞结合剂与一个或多个CC-1065类似物或衍生物在化学上连接的新型细胞毒素药剂。本发明还描述了该细胞毒素药剂的治疗用途。这些细胞毒素药剂具有治疗用途,因为它们以有针对性的方式将细胞毒素药物传递到特定的细胞群体中。